Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy For Locally Advanced Breast Cancer

Running, not enrolling · Not applicable

Conditions studied: Breast Cancer, Locally Advanced Breast Cancer

In brief

This study is being done to help the investigators determine how accurate the sentinel lymph node biopsy (SLNB) procedure is in identifying residual cancer cells after neoadjuvant chemotherapy in patients presenting with locally advanced breast cancer.

Key facts

Study ID
NCT03255577
Run by
Memorial Sloan Kettering Cancer Center
People needed
162
Starts
2017-08-17
Expected to finish
2027-08-30
Last updated by the study team
2026-07-21

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.